Associations between abnormal rod-mediated dark adaptation and health and functioning in older adults with normal macular health

Investigative Ophthalmology and Visual Science

Volumn 55, Issue 8, 2014, Pages 4776-4789

  Owsley, Cynthia ^a   Huisingh, Carrie ^a   Jackson, Gregory R ^b   Curcio, Christine A ^a   Szalai, Alexander J ^c   Dashti, Nassrin ^d   Clark, Mark ^a   Rookard, Kia ^a   McCrory, Mark A ^c   Wright, Tyler T ^c   Callahan, Michael A ^a   Kline, Lanning B ^a   Witherspoon, C Douglas ^a   McGwin Jr , Gerald ^a,e  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c University of Alabama at Birmingham   (United States)

^d University of Alabama at Birmingham   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Age related macular degeneration; Aging; Dark adaptation; Rod function

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3;

ADAPTOMETER; ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD CHEMISTRY; BLOOD SAMPLING; CROSS-SECTIONAL STUDY; DARK ADAPTATION; DISEASE CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EYE PHOTOGRAPHY; FEMALE; HUMAN; HYPERTENSION; MALE; MESOPIC VISION; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL; PSYCHOPHYSICS; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA LUTEA; RETINA ROD; RISK FACTOR; VERY ELDERLY; VISUAL ACUITY;

AGE-RELATED MACULAR DEGENERATION; AGING; DARK ADAPTATION; ROD FUNCTION;

AGED; AGED, 80 AND OVER; AGING; CROSS-SECTIONAL STUDIES; DARK ADAPTATION; FEMALE; HUMANS; MACULA LUTEA; MACULAR DEGENERATION; MALE; MIDDLE AGED; PHOTIC STIMULATION; PSYCHOMETRICS; REFERENCE VALUES; RETINAL ROD PHOTORECEPTOR CELLS; VISUAL ACUITY;

EID: 84905216440     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.14-14502     Document Type: Article

References (89)

1. Steinmetz RL, Haimovici R, Jubb C, Fitzke FW, Bird AC. Symptomatic abnormalities of dark adaptation in patients with age-related Bruch's membrane change. Br J Ophthalmol. 1993; 77: 549-554.
2. Owsley C, Jackson GR, Cideciyan AV, et al. Psychophysical evidence for rod vulnerability in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2000; 41: 267-273.
3. Scholl HPN, Bellmann C, Dandekar SS, Bird AC, Fitzke FW. Photopic and scotopic fine matrix mapping of retinal areas of increased fundus autofluorescence in patients with age-related maculopathy. Invest Ophthalmol Vis Sci. 2004; 45: 574-583.
4. Chen JC, Fitzke FW, Pauleikhoff D, Bird AC. Functional loss in age-related Bruch's membrane change with choroidal perfusion defect. Invest Ophthalmol Vis Sci. 1992; 33: 334-340.
5. Owsley C, Jackson GR, White MF, Feist R, Edwards D. Delays in rod-mediated dark adaptation in early age-related maculopathy. Ophthalmology. 2001; 108: 1196-1202.
6. Owsley C, McGwin G, Jackson G, Kallies K, Clark M. Cone-and rod-mediated dark adaptation impairment in age-related maculopathy. Ophthalmology. 2007; 114: 1728-1735.
7. Clark M, McGwin G, Neely D, et al. Association between retinal thickness measured by spectral-domain OCT and dark adaptation in non-exudative age-related maculopathy. Br J Ophthalmol. 2011; 95: 1427-1432.
8. Mangione CM, Gutierrez PR, Lowe G, Orav EJ, Seddon JM. Influence of age-related maculopathy on visual functioning and health-related quality of life. Am J Ophthalmol. 1999; 128: 45-53.
9. Mangione CM, Lee PP, Gutierrez PR, et al. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001; 119: 1050-1058.
10. Scilley K, Jackson GR, Cideciyan AV, Maguire MG, Jacobson SG, Owsley C. Early age-related maculopathy and self-reported visual difficulty in daily life. Ophthalmology. 2002; 109: 1235-1242.
11. Owsley C, McGwin G Jr, Scilley K, Kallies K. Development of a questionnaire to assess vision problems under low luminance in age-related maculopathy. Invest Ophthalmol Vis Sci. 2006; 47: 528-535.
12. Owsley C, McGwin G, Jackson GR, et al. Effect of short-term, high-dose retinol on dark adaptation in aging and early agerelated maculopathy. Invest Ophthalmol Vis Sci. 2006; 47: 1310-1318.
13. Jackson GR, Owsley C, Curcio CA. Photoreceptor degeneration and dysfunction in aging and age-related maculopathy. Ageing Res Rev. 2002; 1: 381-386.
14. Curcio CA, Jackson GR, Owsley C. Spare the rods, save the cones in aging and age-related maculopathy. Invest Ophthalmol Vis Sci. 2000; 41: 2015-2018.
15. Jackson GR, Clark ME, Scott IU, Walter LE, Quillen DA, Brigell MG. Twelve-month natural history of dark adaptation in patients with AMD [published online ahead of print April 3, 2014]. Optom Vis Sci.
16. Jackson GR, Scott IU, Kim IK, Quillen DA, Iannaccone A, Edwards JG. Diagnostic test sensitivity and specificity of the AdaptDx for the detection of age-related macular degeneration. Invest Ophthalmol Vis Sci. 2014; 55: 1427-1431.
17. Curcio CA, Johnson M, Huang JD, Rudolf M. Aging, age-related macular degeneration, and the response-to-retention of apolipoprotein B-contacting lipoproteins. Prog Retin Eye Res. 2009; 28: 393-422.
18. Curcio CA, Johnson M, Rudolf M, Huang J-D. The oil spill in ageing Bruch's membrane. Br J Ophthalmol. 2011; 95: 1638-1645.
19. Cankova Z, Huang J-D, Kruth H, Johnson M. Passage of lowdensity lipoproteins through Bruch's membrane and choroid. Exp Eye Res. 2011; 93: 947-955.
20. Tserentsoodol N, Sztein J, Campos M, et al. Uptake of cholesterol by the retina occurs primarily via a low density lipoprotein receptor-mediated process. Mol Vis. 2006; 12: 1306-1318.
21. Dowling JE, Wald G. Vitamin A deficiency and night blindness. Proc Natl Acad Sci U S A. 1958; 44: 648-661.
22. Kemp CM, Jacobson SG, Faulkner DJ. The effects of vitamin A deficiency on human visual function. Exp Eye Res. 1988; 46: 185-197.
23. Kemp CM, Jacobson SG, Borruat F-X, Chaitlin MH. Rhodopsin levels and retinal function in cats during recovery from vitamin A deficiency. Exp Eye Res. 1989; 49: 49-65.
24. Katz ML, Chen D-E, Stientjes HJ, Stark WS. Photoreceptor recovery in retinoid-deprived rats after vitamin A replenishment. Exp Eye Res. 1993; 56: 671-682.
25. Kemp CM, Jacobson SG, Faulkner DJ, Walt RW. Visual function and rhodopsin levels in humans with vitamin A deficiency. Exp Eye Res. 1988; 46: 185-196.
26. Lamb TD, Pugh EN Jr. Dark adaptation and the retinoid cycle of vision. Prog Retin Eye Res. 2004; 23: 307-380.
27. Mata NL, Radu RA, Clemmons RS, Travis GH. Isomerization and oxidation of vitamin A in cone-dominant retinas: a novel pathway for visual-pigment regeneration in daylight. Neuron. 2002; 36: 69-80.
28. Garlipp MA, Gonzalez-Fernandez F. Cone outer segment and Muller microvilli pericellular matrices provide binding domains for interphotoreceptor retinoid-binding protein (IRBP). Exp Eye Res. 2013; 113: 192-202.
29. Thompson DA, Gal A. Vitamin A megatherapy for retinal abnormalities. Prog Retin Eye Res. 2003; 22: 683-703.
30. Kim JY, Zhao H, Martinez J, et al. Noncanonical autophagy promotes the visual cycle. Cell. 2013; 154: 365-376.
31. Age-Related Eye Disease Study Research Group. The AgeRelated Eye Disease Study severity scale for age-related macular degeneration. AREDS Report No. 17. Arch Ophthalmol. 2005; 123: 1484-1498.
32. Jackson GR, Owsley C, McGwin G Jr. Aging and dark adaptation. Vision Res. 1999; 39: 3975-3982.
33. Curcio CA, Millican CL, Allen KA, Kalina RE. Aging of the human photoreceptor mosaic: evidence for selective vulnerability of rods in central retina. Invest Ophthalmol Vis Sci. 1993; 34: 3278-3296.
34. Curcio CA, Messinger JD, Sloan KR, McGwin G Jr, Medeiros NE, Spaide RF. Subretinal drusenoid deposits in non-neovascular age-related macular degeneration: morphology, prevalence, topography, and biogenesis model. Retina. 2013; 33: 265-276.
35. Yehoshua Z, Wang F, Rosenfeld PJ, Penha FM, Feurer WJ, Gregori G. Natural history of drusen morphology in age-related macular degeneration using spectral domain optical cohorence tomography. Ophthalmology. 2011; 118: 2434-2441.
36. Thornton J, Edwards R, Mitchell P, Harrison RA, Buchan I, Kelly SP. Smoking and age-related macular degeneration: a review of association. Eye. 2005; 19: 935-944.
37. Seddon JM, Gensler G, Milton RC, Klein ML, Rifai N. Association between c-reactive protein and age-related macular degeneration. JAMA. 2004; 291: 704-710.
38. Snow KK, Seddon JM. Do age-related macular degeneration and cardiovascular disease share common antecedents? Ophthalmic Epidemiol. 1999; 6: 125-143.
39. Sunness JS, Rubin GS, Applegate CA, et al. Visual function abnormalities and prognosis in eyes with age-related geographic atrophy of the macula and good visual acuity. Ophthalmology. 1997; 104: 1677-1691.
40. Hogg RE, Woodside JV, Gilchrist SECM, et al. Cardiovascular disease and hypertension are strong risk factors for choroidal neovascularization. Ophthalmology. 2008; 115: 1046-1052.
41. Seddon JM, Cote J, Davis N, Rosner B. Progression of agerelated macular degeneration: association with body mass index, waist circumference, and waist-hip ratio. Arch Ophthalmol. 2003; 121: 785-792.
42. Shahid H, Khan JC, Cipriani V, et al. Age-related macular degeneration: the importance of family history as a risk factor. Br J Ophthalmol. 2012; 96: 427-431.
43. Chong EW, Kreis AJ, Wong TY, Simpson JA, Guymer RH. Alcohol consumption and the risk of age-related macular degeneration: a systematic review and meta-analysis. Am J Ophthalmol. 2008; 145: 707-715.
44. National Health Interview Survey. Questionnaires, datasets, and related documentation 1997 to the present. Centers for Disease Control and Prevention. 1997. Available at: http: // www. cdc. gov/nchs/nhis/quest_data_related_1997_forward. htm. Accessed March 19, 2014.
45. West SK, Munoz B, Rubin GS, et al. Function and visual impairment in a population-based study of older adults: the SEE Project. Invest Ophthalmol Vis Sci. 1997; 38: 72-82.
46. Owsley C, McGwin G Jr, Sloane ME, Wells J, Stalvey BT, Gauthreaux S. Impact of cataract surgery on motor vehicle crash involvement by older adults. JAMA. 2002; 288: 841-849.
47. Folstein MF, Folstein SW, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12: 189-198.
48. Beck RW, Moke PS, Turpin AH, et al. A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol. Am J Ophthalmol. 2003; 135: 194-205.
49. Pelli DG, Robson JG, Wilkins AJ. The design of a new letter chart for measuring contrast sensitivity. Clin Vision Sci. 1988; 2: 187-199.
50. Elliott DB, Bullimore MA, Bailey IL. Improving the reliability of the Pelli-Robson contrast sensitivity test. Clin Vision Sci. 1991; 6: 471-475.
51. Jackson GR, Edwards JG. A short-duration dark adaptation protocol for assessment of age-related maculopathy. J Ocul Biol Dis Infor. 2008; 1: 7-11.
52. Albers JJ, Marcovina SM, Kennedy H. International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. II. Evaluation and selection of candidate reference materials. Clin Chem. 1992; 38: 658-662.
53. Marcovina SM, Albers JJ, Henderson LO, Hannon WH. International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. III. Comparability of apolipoproteins A-I values by use of international reference material. Clin Chem. 1993; 39: 773-781.
54. Szalai AJ, van Ginkel FW, Wang Y, McGhee JR, Volanakis JE. Complement-dependent acute-phase expression of C-reactive protein and serum amyloid P-component. J Immunol. 2000; 165: 1030-1035.
55. Seddon J, George S, Rosner B, Rifai N. Progression of agerelated macular degeneration: prospective assessment of creactive protein, interleukin 6, and other cardiovascular biomarkers. Arch Ophthalmol. 2005; 123: 774-782.
56. Klein R, Myers CE, Cruickshanks KJ, et al. Markers of inflammation, oxidative stress, and endothelial dysfunction and the 20-year cumulative incidence of early age-related macular degeneration: The Beaver Dam Eye Study. JAMA Ophthalmol. 2014; 132: 446-455.
57. Abramson JL, Hooper WC, Jones DP, et al. Association between novel oxidative stress markers and C-reactive protein among adults without clinical coronary heart disease. Atherosclerosis. 2005; 178: 155-121.
58. Yates JR, Sepp T, Matharu BK, et al. Complement C3 variant and the risk for age-related macular degeneration. New Engl J Med. 2007; 357: 553-561.
59. Du Clos TW. Pentraxins: structure, function, and role in inflammation. ISRN Inflam. 2013; 2013: 379040.
60. Xu H, Chen M, Forrester JV. Para-inflammatin in the aging retina. Prog Retin Eye Res. 2009; 28: 348-368.
61. Ricklin D, Lambris JD. Complement in immune and inflammatory disorders: pathophysiological mechanisms. J Immunol. 2013; 190: 3831-3838.
62. Ricklin D, Lambris JD. Complement in immune and inflammatory disorders: therapeutic interventions. J Immunol. 2013; 190: 3839-3847.
63. Li M, Jia C, Kazmierkiewicz KL, et al. Comprehensive analysis of gene expression in human retina and supporting tissues [published online ahead of print April 1, 2014]. Hum Mol Genet.
64. Johnson PT, Betts KE, Radeke MJ, Hageman GS, Anderson DH, Johnson LV. Individuals homozyous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid. Proc Natl Acad Sci USA. 2006; 103: 17456-17461.
65. Anderson DH, Mullins RF, Hageman GS, Johnson LV. A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol. 2002; 134: 411-431.
66. Bhutto IA, Baba T, Merges C, Juriasinghani V, McLeod DS, Lutty GA. C-reactive protein and complement factor H in aged human eyes and eyes with age-related macular degeneration. Br J Ophthalmol. 2011; 95: 1323-1330.
67. Taskinen S, Hyvonen M, Kovanen PT, Meri S, Pentikainen MO. C-reactive protein binds to the 3beta-OH group of cholesterol in LDL particles. Biochem Biophys Res Commun. 2005; 329: 1208-1216.
68. Laine M, Jarva H, Seitsonen S, et al. Y402H polmorphism of complement factor H affects binding affinity to C-reactive protein. J Immunol. 2007; 178: 3831-3836.
69. Curcio CA, Millican CL, Bailey T, Kruth H. Accumulation of cholesterol with age in human Bruch's membrane. Invest Ophthalmol Vis Sci. 2001; 42: 265-274.
70. Spaide R, Koizumi H, Pozonni M. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol. 2008; 146: 496-500.
71. Khan S, Timney B. Alcohol does not affect dark adaptation or luminance increment thresholds. J Stud Alcohol Drugs. 2007; 68: 493-502.
72. Campbell TD, Sampliner RE, Russell RM, Garrett MS. Night driving (mesopic) visual acuity in sober male alcoholics with and without liver disease. Alcohol Clin Exp Res. 1981; 5: 34-37.
73. Adams MKM, Chong EW, Williamson E, et al. 20/20-alcohol and age-related macular degeneration. Am J Epidemiol. 2012; 176: 289-298.
74. Pearson TA. Nutrition Committee of the American Heart Association. Alcohol and heart disease. Circulation. 1996; 94: 3023-3025.
75. Ronksley PE, Brien S, Turner BJ, Mukamal KJ, Ghali WA. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ. 2011; 342: d671.
76. Imhof A, Froelich M, Brenner H, Boeing H, Pepys MB, Koenig W. Effect of alcohol consumption on systemic markers of inflammation. Lancet. 2001; 357: 763-737.
77. Albert MA, Glynn RJ, Ridker PM. Alcohol consumption and plasma concentration of C-reactive protein. Circulation. 2003; 107: 443-447.
78. Chakravarthy U, Wong TY, Fletcher A, et al. Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol. 2010; 10: 31.
79. Chia E-M, Mitchell P, Rochtchina E, Foran S, Golding M, Wang JJ. Association between vision and hearing impairments and their combined effects on quality of life. Arch Ophthalmol. 2006; 124: 1465-1470.
80. Campbell VA, Crews JE, Moriarty DG, Zack MM, Blackman DK. Surveillance for sensory impairment, activity limitation, and health-related quality of life among older adults: United States, 1993-1997. MMWR CDC Surveill Summ. 1999; 48: 1331-1356.
81. Anstey KJ, Luszez MA, Sanchez L. A reevaluation of the common factor theory of shared variance among age, sensory function, and cognitive function in older adults. J Gerontol B Psychol Sci Soc Sci. 2001; 56B: P3-P11.
82. Klein R, Cruickshanks KJ, Klein BEK, Nondahl DM, Wiley T. Is age-related maculopathy related to hearing loss? Arch Ophthalmol. 1998; 116: 360-365.
83. Klein R, Cruickshanks KJ, Nash SD, et al. The prevelance of age-related macular degeneration and associated risk factors. Arch Ophthalmol. 2010; 128: 750-758.
84. Dashti N, McGwin G, Owsley C, Curcio CA. Plasma apolipoproteins and risk for age related maculopathy. Br J Ophthalmol. 2006; 90: 1028-1033.
85. Li C-M, Presley JB, Zhang X, et al. Retina expresses microsomal triglyceride transfer protein: implications for age-related maculopathy. J Lipid Res. 2005; 46: 628-640.
86. Tserentsoodol N, Gordiyenko NV, Pacual I, Lee JW, Fliesler SJ, Rodriguez IR. Intraretinal lipid transport is dependent on high density lipoprotein-like particles and class B scavenger receptors. Mol Vis. 2006; 12: 1319-1333.
87. Zheng W, Reem R, Omarova S, et al. Spatial distribution of the pathways of cholesterol homeostasis in human retina. PLoS One. 2012; 7: e37926.
88. Martin LM, Leff M, Calonge N, Garrett C, Nelson DE. Validation of self-reported chronic conditions and health services in a managed care population. Am J Prev Med. 2000; 18: 215-218.
89. Bush TL, Miller SR, Golden AL, Hale WE. Self-report and medical record report agreement of selected medical conditions in the elderly. Am J Public Health. 1989; 79: 1554-1556.